title: High-frequency oscillatory ventilation and nitric oxide: alternative or complementary to ECMO.
abstract: One hundred and seventy-seven term or near-term neonates were referred to an ECMO center for severe PPHN-associated diseases. In 2 time periods from 1987 to 1991 and from 1992 to April 1995 alternative treatment modes were tried in an attempt to obviate ECMO. During the first time period patients underwent trial high-frequency oscillatory ventilation before ECMO. In the second time period patients first received inhaled NO followed by HFOV in a non-responders. If this also failed HFOV was combined with INO. In both time periods about 40% of the patients were spared ECMO treatment by these alternative treatment modalities. INO only benefited 15% of the ECMO candidates who apparently had fared just as well on HFOV alone in the preceding time period. While patients who were improved by INO were spared HFOV with its potential severe complications, i.e. air leaks and cardiocirculatory instability, more extended long-term studies will have to show which of these 2 treatment modalities (INO or HFOV) should be given first priority in an attempt to avoid ECMO in neonates with severe respiratory failure.
authors.affiliation: Pediatric Department, Universitäts-Kinderklinik, Mannheim, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Kachel
authors.forename: V
authors.initials: V
authors.lastname: Varnholt
authors.forename: P
authors.initials: P
authors.lastname: Lasch
authors.forename: W
authors.initials: W
authors.lastname: Müller
authors.forename: C
authors.initials: C
authors.lastname: Lorenz
authors.forename: H
authors.initials: H
authors.lastname: Wirth
mesh_terms: D000280:Administration, Inhalation; D001784:Blood Gas Analysis; D003131:Combined Modality Therapy; D015199:Extracorporeal Membrane Oxygenation; D006612:High-Frequency Ventilation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000401:mortality / Q000628:therapy*; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000401:mortality / Q000628:therapy*
chemical_list: D009569:Nitric Oxide